Episode 018Relapsed Myeloma

BCMA Bispecific antibodies - Novel immunotherapies for relapsed myeloma

28 August 2025
40:48

About This Episode

This episode explores bispecific antibodies — how they work, the benefits they bring, and the key side effects patients and carers need to know about.

Previous Episode

017: The Myeloma Transplant Journey: A Nurse's Guide to What Really Happens

Next Episode

019: Four Drugs, One Goal - A New Option for Older Myeloma Patients

The Myeloma Minutes
© The Myeloma Minutes 2026. All rights reserved.
This podcast is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider for medical decisions.
Website by Level 5

Listen

Learn

Support

Connect

Legal

The Myeloma Minutes